Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Jaguar health, inc. crawled time : 13:00 save search
Napo Pharmaceuticals to Exhibit at the October 25-28 Annual Association of Nurses in AIDS Care (ANAC) Conference for Mytesi, the Company’s FDA-Approved Prescription Drug
Published: 2023-10-18 (Crawled : 13:00) - biospace.com/
JAGX | News | $0.1622 -4.53% 4.7M
|
Health Technology
|
| O: -4.27%
H: 8.4%
C: 5.92%
drug conference association care pharmaceuticals
Napo Pharmaceuticals Supports Groundbreaking Study on Quality of Life for Cancer Patients and Survivors
Published: 2023-09-26 (Crawled : 13:00) - biospace.com/
JAGX | News | $0.1622 -4.53% 4.7M
|
Health Technology
|
| O: 0.19%
H: 3.51%
C: -2.33%
life cancer pharmaceuticals study
Jaguar Health's Executive VP Dr. Karen Brunke Joins BIO's Rare Disease and Orphan Drugs Committee
Published: 2023-09-07 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.1622 -4.53% 4.7M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -7.22%
rare disease
Napo Pharmaceuticals, a Jaguar Health Company, Announces Activation by FDA of Investigational New Drug (IND) Application for Crofelemer for Treatment of Microvillus Inclusion Disease
Published: 2023-08-08 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.1622 -4.53% 4.7M
|
Health Technology
|
| O: -0.66%
H: 0.0%
C: 0.0%
fda drug disease health microvillus treatment application crofelemer
Independent Study Published in Clinical Breast Cancer Shows Activity of Jaguar Health's Crofelemer for Neratinib-induced Diarrhea
Published: 2023-08-07 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.1622 -4.53% 4.7M
|
Health Technology
|
| O: 1.2%
H: 3.33%
C: 0.63%
diarrhea breast cancer crofelemer study
Jaguar Health to Present Aug 4th at Wall Street Wonders Investment Group Luncheon in NYC
Published: 2023-08-03 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.1622 -4.53% 4.7M
|
Health Technology
|
| O: -0.75%
H: 0.35%
C: -4.52%
health group wall
REMINDER: Napo Pharmaceuticals, a Jaguar Health Company, Supports Gay Men's Health with Participation in Pineapple Healthcare's "Butt Stuff Brunch with Dr. Carlton" August 5th
Published: 2023-08-02 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.1622 -4.53% 4.7M
|
Health Technology
|
| O: -1.99%
H: 2.02%
C: 0.06%
health
Jaguar Health Announces FDA Activation of Third-Party Investigational New Drug (IND) Application for Evaluation of Crofelemer for Treatment of Uncontrolled Diarrhea in Patient with Short Bowel Syndrome (SBS)
Published: 2023-08-01 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.1622 -4.53% 4.7M
|
Health Technology
|
| O: 1.02%
H: 0.67%
C: -2.84%
fda drug diarrhea health treatment application crofelemer
In Honor of World Nature Conservation Day, Jaguar Health Announces Planting of More Than 1.1 Million Trees in Peruvian Amazon
Published: 2023-07-27 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.1622 -4.53% 4.7M
|
Health Technology
|
| O: 4.99%
H: 0.0%
C: -7.98%
health world amazon
Napo Pharmaceuticals, a Jaguar Health Company, Submits Investigational New Drug (IND) Application to FDA for Microvillus Inclusion Disease
Published: 2023-06-28 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.1622 -4.53% 4.7M
|
Health Technology
|
| O: -0.53%
H: 6.69%
C: 6.28%
fda drug disease health microvillus application
First U.S.-Based Canine Cancer Registry, Founded by Jaguar Health, Joins International Network to Help Advance Canine and Human Cancer Research
Published: 2023-06-26 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.1622 -4.53% 4.7M
|
Health Technology
|
| O: -0.19%
H: 2.86%
C: 2.6%
cancer international research network
Jaguar Health Launching AI-Driven Social Media Disease Awareness Education Series Regarding Cancer Therapy-Related Diarrhea in Dogs and People
Published: 2023-06-22 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.1622 -4.53% 4.7M
|
Health Technology
|
| O: 0.81%
H: 2.66%
C: -5.24%
disease media diarrhea health cancer education
Jaguar Health Subsidiary Becomes Corporate Partner of Multinational Association of Supportive Care in Cancer (MASCC)
Published: 2023-06-20 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.1622 -4.53% 4.7M
|
Health Technology
|
| O: 0.43%
H: 3.88%
C: -1.28%
health association cancer care
Ladenburg Thalmann to Host Virtual Discussion June 22nd with Jaguar Health CEO and Leading Patient Advocates on Impact of Cancer Therapy-related Diarrhea on Patients & Importance of the Patient Voice in Supportive Care
Published: 2023-06-14 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.1622 -4.53% 4.7M
|
Health Technology
|
| O: 1.19%
H: 3.18%
C: 1.71%
ceo diarrhea health cancer care impact
European Pharmaceutical Industry Leader and Entrepreneur Massimo Radaelli, PhD Named Commander of the Italian Republic for Special Merits
Published: 2023-06-07 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.1622 -4.53% 4.7M
|
Health Technology
|
| O: 0.0%
H: 6.83%
C: 6.05%
Jaguar Completes Enrollment in Its Pivotal Phase 3 OnTarget Trial of Crofelemer for Prophylaxis of Cancer Therapy-Related Diarrhea
Published: 2023-05-09 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.1622 -4.53% 4.7M
|
Health Technology
|
| O: -0.68%
H: 0.54%
C: -6.28%
diarrhea cancer crofelemer trial
Jaguar Health to Hold Investor Webcast Monday, May 15th at 8:30 AM EDT Regarding Q1 2023 Financials & Corporate Updates
Published: 2023-05-08 (Crawled : 13:00) - biospace.com/
JAGX | News | $0.1622 -4.53% 4.7M
|
Health Technology
|
| O: 1.56%
H: 18.03%
C: 12.31%
health
Napo Therapeutics Sponsoring Pediatric Gastroenterology Conference: Elite Ped-GI Congress in Abu Dhabi
Published: 2023-05-01 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.1622 -4.53% 4.7M
|
Health Technology
|
| O: 3.25%
H: 7.77%
C: 2.91%
therapeutics
U.S. Veterinary Oncologists Participating in a New Survey Prefer Canalevia-CA1 Over the Current Standard of Care
Published: 2023-04-27 (Crawled : 13:00) - jaguarhealth.gcs-web.com
JAGX | News | $0.1622 -4.53% 4.7M
|
Health Technology
|
| O: -5.45%
H: 3.85%
C: 0.0%
veterinary care
Patient Enrollment Surpasses 90% in Jaguar Health's Pivotal Phase 3 OnTarget Trial of Crofelemer for Cancer Therapy-Related Diarrhea
Published: 2023-04-11 (Crawled : 13:00) - biospace.com/
JAGX | News | $0.1622 -4.53% 4.7M
|
Health Technology
|
| O: 0.94%
H: 11.89%
C: 8.26%
diarrhea cancer crofelemer trial
Gainers vs Losers
| 46% | 54% |
Top 10 Gainers
SGBX | $0.26 80.43% 54M
|
Producer Manufacturing
LICN | $1.0 78.57% 3.3M
|
CSSE 4 | $0.2656 74.39% 9.7M
|
Consumer Services
BRFH 4 | $1.89 71.82% 32M
|
Manufacturing
ACON | $0.49 70.14% 24M
|
n/a
BOF | $1.95 66.67% 920K
|
MTC | $3.62 61.61% 790K
|
Technology Services
AMST | $3.22 61.0% 720K
|
Technology Services
PCSA | $2.28 40.74% 37M
|
Producer Manufacturing
EVA | $0.626 39.14% 2.3M
|
Process Industries
Your saved searches
Save your searches and get alerts when important news are released.